National Institutes of Health (NIH) Awards Funding to University of California, San Francisco (UCSF) for the Discovery of Antimalarial Agents in Collaboration with Anacor Pharmaceuticals, Inc.  
10/11/2011 11:34:38 AM

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that the University of California San Francisco (UCSF) has been awarded $718,136 in funding from the National Institutes of Health (NIH) to discover and optimize novel oxaboroles as antimalarial drugs in collaboration with Anacor Pharmaceuticals. The NIH grant provides support for the period beginning September 30, 2011 and ending September 29, 2012.